Abstract:Nutritional strategy employed during pregnancy has a significant impact on pregnancy progression and outcome. However, there is paucity of evidence on the effect of omega (n)‐3 polyunsaturated fatty acids (PUFA) intake on maternal metabolic regulation and fetal outcome at different stages of pregnancy. We investigated the effects of diets varying in both the quantity and the quality of fat on maternal metabolic profile during pregnancy and its effect on the fetal number of C57BL/6 mice. Female mice (8 weeks) were fed diets varying in the quantity of fat (5% vs. 11%) for one week prior to mating and throughout pregnancy. The 5% diet contained fish oil as a source of n‐3 PUFA, while the 11% diet contained soybean oil. The females were checked for vaginal plug to confirm pregnancy. Maternal blood and livers were collected at early‐ (day 6.5), mid‐ (day 12.5) and late‐pregnancy (day 18.5). Lipids were extracted from red blood cells (RBC) and liver, and fatty acid composition was determined using gas chromatography. Plasma and liver triacylglycerol (TG) and total cholesterol (TC) were measured using kits. Hepatic mRNA expression of lipogenic enzymes (acetyl‐CoA carboxylase; ACC1 and fatty acid synthase; FAS) was measured using qPCR. Macrophage cholesterol efflux assay was performed using J774 cells treated with 2% maternal plasma. Plasma progesterone and estradiol were determined using Architect System. Fetal weight, implantation sites and the number of fetuses sustained throughout pregnancy were recorded. Two way analysis of variance was used to determine the main effects of diet and time, and Bonferrroni pairwise comparison was used to determine statistical difference when an interaction was observed; P<0.05 was considered significant. The 5% diet group had higher amount of RBC alpha‐linolenic acid (ALA), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) at each stage of pregnancy, compared to the 11% group (P<0.0001). Interestingly, ALA was not detected at day 12.5 and 18.5 in the 11% group. The 5% group showed higher plasma TG (P<0.001) and lower TC (P<0.05), compared to the 11% group at mid and late pregnancy. Hepatic TC levels were higher in the 5% group, compared to the 11% group (P<0.05) at mid and late pregnancy. The plasma from the 5% group at mid and late pregnancy increased cholesterol efflux, compared to the 11% group (P<0.005). The mRNA expression of ACC1 and FAS were higher in the 5% group, compared to the 11% group (P<0.05) at mid and late pregnancy. Diet had an independent effect on maternal sex‐hormones, revealing significantly higher levels of progesterone and estradiol in the 5% group (P<0.005), compared to the 11% group. The number of fetuses sustained till day 18.5 was higher in the 5% group (average of 8 fetuses), compared to the 11% group (average of 5.1 fetuses) (P<0.05). In conclusion, a low fat diet causes an increase in de‐novo lipid synthesis, likely to meet the needs of the developing fetus. The 11% group showed rapid conversion of ALA to DHA at mid and late gestation. Higher levels of progesterone and estradiol in the 5% group may be responsible for sustaining a higher fetal number. Our findings highlight the importance of the quantity and the quality of fat during pregnancy on fetal outcome. Support or Funding Information Funded by Natural Sciences and Engineering Research Council of Canada (NSERC)

Maternal Plasma L-Carnitine Reduction During Pregnancy is Mainly Attributed to OCTN2-Mediated Placental Uptake and Does Not Result in Maternal Hepatic Fatty Acid Β-Oxidation Decline.

Gestational Exposure to Ambient Fine Particulate Matter Disrupts Maternal Hepatic Lipid Metabolism.

Downregulations of Placental Fatty Acid Transporters During Cadmium-Induced Fetal Growth Restriction.

Transcriptome Profiling of Placenta Through Pregnancy Reveals Dysregulation of Bile Acids Transport and Detoxification Function.

L‐carnitine Increases Cell Proliferation and Amino Acid Transporter Expression Via the Activation of Insulin‐like Growth Factor I Signaling Pathway in Rat Trophoblast Cells

Association of acylcarnitines with maternal cardiometabolic risk factors is defined by chain length: the S-PRESTO study

Plasma Acylcarnitines during Pregnancy and Neonatal Anthropometry: A Longitudinal Study in a Multiracial Cohort

Maternal Eicosapentaenoic Acid Feeding Decreases Placental Lipid Deposition and Improves the Homeostasis of Oxidative Stress Through a Sirtuin-1 (SIRT1) Independent Manner

Alteration in placental expression of bile acids transporters OATP1A2, OATP1B1, OATP1B3 in intrahepatic cholestasis of pregnancy

Effects of Maternal High-Fat Diet on Fetal Growth, Placental Nutrient Transporters and Circular RNA Expression Profiles.

Maternal Choline Supplementation Modulates Placental Nutrient Transport and Metabolism in Late Gestation of Mouse Pregnancy.

L-carnitine and Fat Type in the Maternal Diet During Gestation and Lactation Modify the Fatty Acid Composition and Expression of Lipid Metabolism-Related Genes in Piglets

Lycopene Modulates Placental Health and Fetal Development under High-Fat Diet During Pregnancy of Rats.

IGF2 May Enhance Placental Fatty Acid Metabolism by Regulating Expression of Fatty Acid Carriers in the Growth of Fetus and Placenta During Late Pregnancy in Pigs.

Up‐regulation of hepatic CD36 by increased corticosterone/cortisol levels via GR leads to lipid accumulation in liver and hypertriglyceridaemia during pregnancy

Effect of maternal high-fat diet on placental phenotype in mice

Maternal nutrient metabolism in the liver during pregnancy

Maternal Curcumin Supplementation Ameliorates Placental Function and Fetal Growth in Mice with Intrauterine Growth Retardation†

Maternal folic acid and vitamin B12 supplementation during medium to late gestation promotes fetal development via improving placental antioxidant capacity, angiogenesis and amino acid transport

[Expression of Long Chain Fatty Acid Oxidase in Maternal and Fetal Tissues in Preeclampsia-Like Mouse Model in Mid-Gestation].

A Maternal Diet Enriched with Longer Chain Omega‐ 3 Polyunsaturated Fatty Acids Increased Lipogenesis and Fetal Outcome in C57bl/6 Mice